Treatment of sporadic inclusion body myositis with bimagrumab

OBJECTIVE: To study activin signaling and its blockade in sporadic inclusion body myositis (sIBM) through translational studies and a randomized controlled trial. METHODS: We measured transforming growth factor β signaling by SMAD2/3 phosphorylation in muscle biopsies of 50 patients with neuromuscul...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurology
Main Authors: Amato, Anthony A., Sivakumar, Kumaraswamy, Goyal, Namita, David, William S., Salajegheh, Mohammad, Praestgaard, Jens, Lach-Trifilieff, Estelle, Trendelenburg, Anne-Ulrike, Laurent, Didier, Glass, David J., Roubenoff, Ronenn, Tseng, Brian S., Greenberg, Steven A.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4277670/
https://ncbi.nlm.nih.gov/pubmed/25381300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001070
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados